Key facts
- Inito’s last known valuation is $3.6M (Dec 2017).
- It has raised $37.7M; the latest was Later Stage VC ($29.0M) in Dec 2025.
- Notable investors include Y Combinator, Astir Ventures, 2468 Ventures, Fireside Ventures, Kishore Ganji — 21 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 21 names
- ·Watchlist + deal alerts for Inito
- ·The full record, as it builds
Funding rounds
No funding rounds for Inito are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Inito
Developer of an at-home fertility monitoring device designed to track hormone levels and confirm ovulation for deeper reproductive health insights. The company offers a device with multi-hormone tracking, personalized fertility analysis, and an extensive global test database, enabling individuals seeking fertility guidance and broader hormonal health understanding to make informed decisions about their reproductive well-being.
- Sector
- Healthcare
- HQ
- Bengaluru, India
- Founded
- 2012
- Employees
- 200
- Website
- inito.com/
- Ownership
- Privately Held (backing)
Inito doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Inito shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Inito in its N-PORT filings yet. We sweep new filings monthly.